{"id":2110,"date":"2025-07-18T13:31:35","date_gmt":"2025-07-18T04:31:35","guid":{"rendered":"https:\/\/www.lifescience.shokubai.co.jp\/?post_type=news&#038;p=2110"},"modified":"2025-07-18T13:31:43","modified_gmt":"2025-07-18T04:31:43","slug":"poster-presentation-at-the-10th-annual-meeting-of-the-nucleic-acids-therapeutics-society-of-japan-optimization-of-analytical-conditions-for-ion-pair-reversed-phase-liquid-chromatography-of-oligonucle","status":"publish","type":"news","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/","title":{"rendered":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]"},"content":{"rendered":"\n<p class=\"has-medium-font-size wp-block-paragraph\">We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1<sup>st<\/sup> to 3<sup>rd<\/sup>, 2025, and we would like to introduce the content published in the abstracts collection.<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-1\" style=\"color:#026745\">Presentation<\/h2>\n\n\n\n<figure class=\"wp-block-table is-style-regular\"><table><tbody><tr><td><strong>Title<\/strong><\/td><td>Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments<\/td><\/tr><tr><td><strong>Presenter<\/strong><\/td><td><strong>Kaho Maeda<\/strong><br>Research &amp; Development Department, Health &amp; Medical Business Division,<br>NIPPON SHOKUBAI CO., LTD.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-2\" style=\"color:#026745\">Background<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Oligonucleotide therapeutics synthesized chemically may contain various types of impurities, such as N-1, N+1, and PS\u2192PO. In current quality control practices, ion-pair reversed-phase chromatography (IP-RP) is commonly used to separate and evaluate these impurities. The separation of impurities is influenced by analytical parameters such as ion-pair reagents and the gradient. Recently, the concept of Analytical Quality by Design (AQbD), which systematically develops analytical methods based on science and risk, has gained attention as a method for rapidly developing robust and reliable testing methods.<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-3\" style=\"color:#026745\">Research Contents<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In this study, we developed a method to rapidly optimize multiple analytical parameters of ion-pair reversed-phase chromatography (IP-RP) using design of experiments (DOE). The analysis target was a 16-mer phosphorothioate oligonucleotide with six types of impurities added. The concentration of ion-pair reagents, column temperature, and gradient were examined as analytical parameters. Twenty experimental conditions were set using space-filling designs, and experiments were conducted using IP-RP. From the obtained data, a model predicting the peak width and retention time of each impurity was created using response surface methodology, and the experimental conditions to achieve the target separation resolution were predicted. The experiments conducted under these conditions yielded results that generally matched the predicted separation resolution. Additionally, the impact of each analytical parameter on separation was systematically understood. This method could be applied not only to IP-RP but also to various separation modes of liquid chromatography. By evaluating the interactions between parameters based on AQbD, it is expected to lead to the acquisition of a very extensive knowledge base.<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1080\" height=\"1124\" src=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/07\/\u524d\u7530\u3055\u3093_\u4ed6\u793e\u30dd\u30b9\u30bf\u30fc\u307c\u304b\u3057\u6e08.jpg\" alt=\"\" class=\"wp-image-2091\" srcset=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/07\/\u524d\u7530\u3055\u3093_\u4ed6\u793e\u30dd\u30b9\u30bf\u30fc\u307c\u304b\u3057\u6e08.jpg 1080w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/07\/\u524d\u7530\u3055\u3093_\u4ed6\u793e\u30dd\u30b9\u30bf\u30fc\u307c\u304b\u3057\u6e08-288x300.jpg 288w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/07\/\u524d\u7530\u3055\u3093_\u4ed6\u793e\u30dd\u30b9\u30bf\u30fc\u307c\u304b\u3057\u6e08-984x1024.jpg 984w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/07\/\u524d\u7530\u3055\u3093_\u4ed6\u793e\u30dd\u30b9\u30bf\u30fc\u307c\u304b\u3057\u6e08-768x799.jpg 768w\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" \/><figcaption class=\"wp-element-caption\">Poster presentation<\/figcaption><\/figure>\n<\/div>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-color has-link-color wp-elements-4\" style=\"color:#026745\">Meeting Information<\/h2>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td>Name<\/td><td>&nbsp;The 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan<\/td><\/tr><tr><td>Meeting<\/td><td> July 1<sup>st<\/sup> (Tue) \u2013 July 3<sup>rd<\/sup> (Thu), 2025<\/td><\/tr><tr><td>Venue<\/td><td> Kobe International Exhibition Hall No.\u202f2<\/td><\/tr><tr><td>Official website<\/td><td>&nbsp;<a href=\"https:\/\/www.natsj.jp\/2025\/natsj10\" target=\"_blank\" rel=\"noopener\" title=\"\">https:\/\/www.natsj.jp\/2025\/natsj10<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":0,"template":"","news_category":[16],"class_list":["post-2110","news","type-news","status-publish","hentry","news_category-technical-information-en"],"acf":{"blank_url":"","pdf_url":null,"select_link":"single_link"},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI\" \/>\n\t\t<meta property=\"og:description\" content=\"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-07-18T04:31:35+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-07-18T04:31:43+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI\" \/>\n\t\t<meta name=\"twitter:description\" content=\"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"position\":1,\"name\":\"\\u5bb6\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"name\":\"Technical Info\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"name\":\"\\u5bb6\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"position\":3,\"name\":\"Technical Info\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/#listItem\",\"name\":\"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/#listItem\",\"position\":4,\"name\":\"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/technical-information-en\\\/#listItem\",\"name\":\"Technical Info\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/#webpage\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/\",\"name\":\"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI\",\"description\":\"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/2110\\\/#breadcrumblist\"},\"datePublished\":\"2025-07-18T13:31:35+09:00\",\"dateModified\":\"2025-07-18T13:31:43+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI","description":"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types","canonical_url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","position":1,"name":"\u5bb6","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","position":2,"name":"News","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","name":"Technical Info"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","name":"\u5bb6"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","position":3,"name":"Technical Info","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/#listItem","name":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/#listItem","position":4,"name":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]","previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/#listItem","name":"Technical Info"}}]},{"@type":"Organization","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"@type":"WebPage","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/#webpage","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/","name":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI","description":"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/#breadcrumblist"},"datePublished":"2025-07-18T13:31:35+09:00","dateModified":"2025-07-18T13:31:43+09:00"},{"@type":"WebSite","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","og:type":"article","og:title":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI","og:description":"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types","og:url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/","article:published_time":"2025-07-18T04:31:35+00:00","article:modified_time":"2025-07-18T04:31:43+00:00","twitter:card":"summary_large_image","twitter:title":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments] | NIPPON SHOKUBAI","twitter:description":"We gave a poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan, held at Kobe International Exhibition Hall No. 2 from July 1st to 3rd, 2025, and we would like to introduce the content published in the abstracts collection. Presentation Background Oligonucleotide therapeutics synthesized chemically may contain various types"},"aioseo_meta_data":{"post_id":"2110","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2025-07-18 00:35:02","updated":"2025-07-18 04:37:22","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/\" title=\"\u5bb6\">\u5bb6<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/\" title=\"Technical Info\">Technical Info<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tPoster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan &#91;Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments&#93;\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u5bb6","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"label":"News","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/"},{"label":"Technical Info","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/technical-information-en\/"},{"label":"Poster presentation at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan [Optimization of Analytical Conditions for Ion-Pair Reversed-Phase Liquid Chromatography of Oligonucleotides Using Design of Experiments]","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2110\/"}],"_links":{"self":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":0,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2110\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=2110"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news_category?post=2110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}